FOR RESEARCH USE ONLY · NOT FOR HUMAN OR VETERINARY USE
YZF PeptideResearch supply
Back to catalog

Research product specification

SM2

Semaglutide

For Research Use Only. Not for human or veterinary use.

Semaglutide is listed for legitimate laboratory and research procurement. This 99%+ research-use product is available in 6 listed specifications. Review product codes, storage guidance and COA status, then request a wholesale quotation. Published COA documentation is available for selected specifications.

Listed purity
99%+
Availability
Available for inquiry
Select specification2mg x 10vials

COA available

COACOA available

Volume discounts are available for larger purchasing plans. Please contact us for a quotation.

Delivery includedUsually within 7 days after dispatch

Quality resolutionRefund or replacement when approved

24/7 contactWholesale assistance on WhatsApp

Product profile

About Semaglutide

Semaglutide is a synthetic long-acting glucagon-like peptide-1 (GLP-1) receptor agonist, belonging to the next generation of incretin mimetics. It works by activating GLP-1 receptors to stimulate glucose-dependent insulin secretion, suppress glucagon release, significantly delay gastric emptying, and induce satiety signals through central nervous system action. With its exceptional efficacy in glycemic control and weight reduction, semaglutide has been widely adopted for the management of type 2 diabetes and obesity. Its extended half-life allows for once‑weekly administration, greatly enhancing treatment convenience.

Main functions

  • "1.Significant Weight Reduction: Promotes sustainable weight loss by suppressing appetite, delaying gastric emptying, and enhancing feelings of fullness.
  • 2.Precise Glycemic Control: Stimulates insulin secretion in a glucose‑dependent manner, reducing fasting and postprandial blood glucose with a low risk of hypoglycemia.
  • 3.Cardiovascular Protection: Clinical trials have demonstrated a reduction in major adverse cardiovascular events, offering additional heart health benefits.
  • 4.Improves Lipid Profile: Helps lower total cholesterol, LDL‑C, and triglycerides, contributing to better metabolic health.
  • 5.Improves Non‑Alcoholic Fatty Liver Disease: Reduces hepatic fat accumulation, showing potential therapeutic value for NAFLD patients.
  • 6.Convenient Dosing Regimen: Once‑weekly subcutaneous injection significantly improves treatment adherence."

Recommended audience

  • Overweight or obese individuals seeking effective weight management, with or without type 2 diabetes.
  • Patients with type 2 diabetes, particularly those who require both glycemic control and weight loss.
  • Individuals at cardiovascular risk who may benefit from additional cardioprotective effects.
  • Users who prefer a longer‑acting, more convenient alternative to daily injection regimens.
Order formatOne box accepted
QuotationConfirmed on WhatsApp
DeliveryShipping and duties included
DocumentationPublished COA or available on request

Research product specification

Product information

Semaglutide is listed for legitimate laboratory and research procurement. This 99%+ research-use product is available in 6 listed specifications. Review product codes, storage guidance and COA status, then request a wholesale quotation. Published COA documentation is available for selected specifications.

Handling information

Storage guidance

Keep unopened lyophilized products protected from light and moisture; store at 2-8°C short term or -20°C long term. After reconstitution, refrigerate according to product documentation and minimize freeze-thaw cycles.

Customer-first resolution

Report quality concerns within 14 days of delivery

Contact us with the order number, batch details and available photos. Opened products are accepted for review. When a quality claim is approved, you may choose a full refund or replacement shipment.